Skip to content

Clinical trials

Terminated Phase 1/2 trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Terminated Country / region: Switzerland Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20082
20091
20102
20111
20125
20131
20143
20153
20161
20175
20183
20194
20202
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Swiss Cancer Institute4
Bristol-Myers Squibb3
Hoffmann-La Roche2
Institute of Cancer Research, United Kingdom2
Ipsen2
ANRS, Emerging Infectious Diseases1
Advanced Accelerator Applications1
Alentis Therapeutics AG1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma3
Melanoma3
Neoplasms3
Brain Neoplasms2
Breast Neoplasms2
Carcinoma, Hepatocellular2
Colorectal Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Adenocarcinoma of Lung1
Arthritis, Rheumatoid1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.